February 18, 2025Real-World Data Support Rituximab Plus Lenalidomide in NHLA chemotherapy-free combination therapy shows promise for patients with relapsed/refractory (RR) indolent non-Hodgkin lymphoma (iNHL), according to a new real-world study. The analysis, published in Haematologica, […]